Tablets & Capsules — Ask an Expert: Modifying a Previously Approved Sustained-Release Formulation

Wayne Wiley, senior director of regulatory affairs at Recro, explains how to avoid additional clinical studies when modifying a previously approved sustained-release formulation. Read the article on CMC filing to meet FDA expectations under the SUPAC guidance for modified release oral solid dosage forms.

Want to know more?

Read the article

Back to Thought Leadership